INSM250117C62500
- 4.00
- -5.30-56.99%
Insmed Newsroom
Insmed (INSM) Gets a Buy From Evercore ISI
Truist Financial Maintains Insmed(INSM.US) With Buy Rating
Wells Fargo Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $85
Insmed's Promising Growth: Buy Rating Backed by Strong Performance and Strategic Advancements
TD Cowen Maintains Insmed(INSM.US) With Buy Rating
TD Cowen Reaffirms Their Buy Rating on Insmed (INSM)
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Insmed Issues Preliminary Revenue Results, Guidance for Arikayce
Insmed Projects Revenue Growth and Advances Drug Pipeline
Express News | Insmed Inc: Narrowing Timing for Expected U.S. Launch for Brensocatib in Bronchiectasis to Q3 of 2025
Express News | Insmed Outlook FY Revenue USD 405-425 Million
Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference
Unpleasant Surprises Could Be In Store For Insmed Incorporated's (NASDAQ:INSM) Shares
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Express News | Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Unusual Options Activity: MCHP, INSM and Others Attract Market Bets, MCHP V/OI Ratio Reaches 326.1
EST Dec 5th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
How Is The Market Feeling About Insmed?
Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?
Insmed Insiders Sold US$3.8m Of Shares Suggesting Hesitancy